CCNB1 and melanoma: To further validate the specific role of CCNB1 in mediating melanoma cell resistance to NK cell cytotoxicity, we co-cultured NK-92MI cells with melanoma cells at an E:T ratio of 10:1, as shown in Figure 5A. Flow cytometry was used to assess changes in NK activation markers and cytotoxic effector.